ad image

Agreement

1 / 2
HALIX
COVID-19 Vaccine

HALIX Signs Agreement With AstraZeneca For Commercial Manufacture Of COVID-19 Vaccine

HALIX

PR-M11-20-031Dec 10, 2020
PPD, part of Thermo Fisher Scientific
Agreement

PPD Signs New Service Agreement with Pfizer

PPD, part of Thermo Fisher Scientific

PR-M08-20-NI-08Aug 04, 2020
SGS Life Science Services
COVID-19 Vaccine

SGS Signs Analytical Testing Agreement with AstraZeneca for COVID-19 Vaccine Candidate

SGS Life Science Services

PR-M07-20-NI-28Jul 17, 2020
Catalent
COVID-19 Vaccine

Catalent Signs Agreement with Johnson & Johnson to be U.S. Manufacturing Partner for Lead COVID-19 Vaccine Candidate

Catalent

PR-M04-20-NI-044-1583Apr 30, 2020
Lonza
Agreement

Cellectis and Lonza Enter cGMP Manufacturing Service Agreement for Cellectis’ Allogeneic UCART Product Candidates

Lonza

PR-M10-19-NI-006Oct 04, 2019
Vertex
Agreement

Vertex Announces New Access Agreement with Scottish Government for ORKAMBI® (lumacaftor/ivacaftor) and SYMKEVI® (tezacaftor/ivacaftor)

Vertex

PR-M09-19-NI-041Sep 16, 2019
iBio, Inc.
3D Bioprinting

iBio Inks 3D Bioprinting Agreement

iBio, Inc.

PR-M08-19-NI-058Aug 20, 2019
Avid Bioservices
Contract Manufacturing

Avid Bioservices Enters into Contract Manufacturing Agreements with New and Existing Customers

Avid Bioservices

PR-M07-19-NI-030Jul 12, 2019
Emergex Vaccines Holding Limited

Emergex Signs an R&D Agreement with IMCB to Develop a Vaccine for the Emerging Threat of Hand, Foot & Mouth Disease

Emergex Vaccines Holding Limited

PR-M07-19-NI-031Jul 12, 2019
Eisai
Agreement

Eisai and Empatica Enter an Agreement to Co-Promote the Embrace2 Device for People Living With Epilepsy in the U.S.

Eisai

PR-M02-19-NI-048Feb 21, 2019
Johnson & Johnson
Acquisition

Johnson & Johnson Announces Agreement to Acquire Auris Health, Inc.

Johnson & Johnson

PR-M02-19-NI-036Feb 15, 2019
UPMC Health Plan
Agreement

UPMC Health Plan Announces Innovative, Value-Based Agreement with AstraZeneca

UPMC Health Plan

PR-M01-19-NI-084Jan 29, 2019
U.S. Department of Veterans Affairs Signs Contract with Merck for its Remicade Biosimilar
Biosimilars

U.S. Department of Veterans Affairs Signs Contract with Merck for its Remicade Biosimilar

Nice Insight

PAO-M10-18-NI-010Oct 12, 2018
Glenmark Pharmaceuticals
Agreement

Glenmark Pharmaceuticals and Harbour BioMed Sign Agreement for Greater China to Develop GBR 1302, a First-in-Class Bispecific Antibody for Treatment of HER2-Positive Cancers

Glenmark Pharmaceuticals

PR-M08-18-NI-050Aug 13, 2018
Leiters
Preferred Provider

Leiters and Avanos Medical Announce Preferred Provider Agreement

Leiters

PR-M07-18-NI-054Jul 17, 2018
Boehringer Ingelheim
Animal Health

LEUKOCARE and Boehringer Ingelheim Enter into a Long-Term Agreement in the Field of Animal Health

Boehringer Ingelheim

PR-M04-18-NI-53Apr 16, 2018
J&J Involved in Probiotics Development Program
Probiotics

J&J Involved in Probiotics Development Program

Emilie Branch

Pharma's Almanac

PR-M03-18-NI-100Mar 29, 2018
LenioBio GmbH
Licensing

Protein Science to Advance Through LenioBio and Dow AgroSciences License Agreement

LenioBio GmbH

PR-M03-18-NI-064Mar 19, 2018
Grifols
Distribution

Grifols Announces New Agreement with Henry Schein to Distribute Normal Saline Solution in the U.S.

Grifols

PR-M03-18-NI-018Mar 06, 2018
Abarca
Agreement

Abarca, Amgen Enter Outcomes-Based Agreement For Repatha® (evolocumab)

Abarca

PR-M02-18-NI-103Feb 28, 2018
1 / 2